Skip to main content
Erschienen in: European Radiology 8/2020

12.05.2020 | Editorial Comment

Abbreviated MRI for HCC surveillance: is it ready for clinical use?

verfasst von: Naik Vietti Violi, Bachir Taouli

Erschienen in: European Radiology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Key Points

Abbreviated MRI (AMRI) protocols consist of acquiring only a minimal number of MRI sequences for HCC surveillance with acceptable diagnostic performance compared to complete MRI.
AMRI protocol options include non-contrast AMRI, dynamic AMRI or hepatobiliary phase AMRI post gadoxetate injection.
The best AMRI protocol for HCC surveillance needs to be defined in a large multicentre prospective study.
Literatur
1.
Zurück zum Zitat Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130:417–422PubMed Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130:417–422PubMed
2.
Zurück zum Zitat European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 69:182–236 European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 69:182–236
3.
Zurück zum Zitat Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750CrossRef Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750CrossRef
4.
Zurück zum Zitat Tzartzeva K, Obi J, Rich NE et al (2018) Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology 154:1706–1718 e1701CrossRef Tzartzeva K, Obi J, Rich NE et al (2018) Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology 154:1706–1718 e1701CrossRef
5.
Zurück zum Zitat Kim SY, An J, Lim YS et al (2017) MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. JAMA Oncol 3:456–463CrossRef Kim SY, An J, Lim YS et al (2017) MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. JAMA Oncol 3:456–463CrossRef
6.
Zurück zum Zitat Besa C, Lewis S, Pandharipande PV et al (2017) Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid. Abdom Radiol (NY) 42:179–190CrossRef Besa C, Lewis S, Pandharipande PV et al (2017) Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid. Abdom Radiol (NY) 42:179–190CrossRef
7.
Zurück zum Zitat Park HJ, Jang HY, Kim SY et al (2020) Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: comparison with ultrasound. J Hepatol 72:718–724 Park HJ, Jang HY, Kim SY et al (2020) Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: comparison with ultrasound. J Hepatol 72:718–724
8.
Zurück zum Zitat Khatri G, Pedrosa I, Ananthakrishnan L et al (2020) Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: an equivalence study using LI-RADS v2018. J Magn Reson Imaging 51:415–425 Khatri G, Pedrosa I, Ananthakrishnan L et al (2020) Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: an equivalence study using LI-RADS v2018. J Magn Reson Imaging 51:415–425
9.
Zurück zum Zitat Marks RM, Ryan A, Heba ER et al (2015) Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR Am J Roentgenol 204:527–535CrossRef Marks RM, Ryan A, Heba ER et al (2015) Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR Am J Roentgenol 204:527–535CrossRef
10.
Zurück zum Zitat Whang S, Choi MH, Choi JI, Youn SY, Kim DH, Rha SE (2020) Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas. Eur Radiol. https://doi.org/10.1007/s00330-020-06754-4 Whang S, Choi MH, Choi JI, Youn SY, Kim DH, Rha SE (2020) Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas. Eur Radiol. https://​doi.​org/​10.​1007/​s00330-020-06754-4
11.
Zurück zum Zitat Tillman BG, Gorman JD, Hru JM et al (2018) Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. Clin Radiol 73:485–493CrossRef Tillman BG, Gorman JD, Hru JM et al (2018) Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. Clin Radiol 73:485–493CrossRef
12.
Zurück zum Zitat Lima PH, Fan B, Berube J et al (2019) Cost-utility analysis of imaging for surveillance and diagnosis of hepatocellular carcinoma. AJR Am J Roentgenol:1–9 Lima PH, Fan B, Berube J et al (2019) Cost-utility analysis of imaging for surveillance and diagnosis of hepatocellular carcinoma. AJR Am J Roentgenol:1–9
Metadaten
Titel
Abbreviated MRI for HCC surveillance: is it ready for clinical use?
verfasst von
Naik Vietti Violi
Bachir Taouli
Publikationsdatum
12.05.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06904-8

Weitere Artikel der Ausgabe 8/2020

European Radiology 8/2020 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.